Taclonex Scalp
NDC 54868-6091
Product Information
Taclonex Scalp is a NDA-approved product labeled by Physicians Total Care, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 54868-6091 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 54868-6091?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CALCIPOTRIENE (UNII: 143NQ3779B)
- CALCIPOTRIENE (UNII: 143NQ3779B) (Active Moiety)
- BETAMETHASONE DIPROPIONATE (UNII: 826Y60901U)
- BETAMETHASONE (UNII: 9842X06Q6M) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYDROGENATED CASTOR OIL (UNII: ZF94AP8MEY)
- MINERAL OIL (UNII: T5L8T28FGP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 833461 - calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Suspension
- RxCUI: 833461 - betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion
- RxCUI: 833461 - betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Suspension
- RxCUI: 833463 - Taclonex Scalp (calcipotriene 0.005 % / betamethasone dipropionate 0.064 % ) Topical Suspension
- RxCUI: 833463 - betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion [Taclonex]
* Please review the full disclaimer at the bottom of this page.